During the last session, Nevro Corp (NYSE:NVRO)’s traded shares were 0.54 million, with the beta value of the company hitting 0.85. At the end of the trading day, the stock’s price was $4.52, reflecting an intraday gain of 3.67% or $0.16. The 52-week high for the NVRO share is $22.64, that puts it down -400.88 from that peak though still a striking 12.61% gain since the share price plummeted to a 52-week low of $3.95. The company’s market capitalization is $169.38M, and the average intraday trading volume over the past 10 days was 1.03 million shares, and the average trade volume was 550.29K shares over the past three months.
Nevro Corp (NVRO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.47. NVRO has a Sell rating from 2 analyst(s) out of 15 analysts who have looked at this stock. 6 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.79.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Nevro Corp (NYSE:NVRO) trade information
The stock spiked 3.67% in intraday trading to $4.52, hitting a weekly high. The stock’s 5-day price performance is 0.00%, and it has moved by -6.80% in 30 days. Based on these gigs, the overall price performance for the year is -72.29%. The short interest in Nevro Corp (NYSE:NVRO) is 3.14 million shares and it means that shorts have 9.16 day(s) to cover.
The consensus price target of analysts on Wall Street is $7, which implies an increase of 35.43% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $125 respectively. As a result, NVRO is trading at a discount of -2665.49% off the target high and -10.62% off the low.
Nevro Corp (NVRO) estimates and forecasts
Statistics show that Nevro Corp has underperformed its competitors in share price, compared to the industry in which it operates. Nevro Corp (NVRO) shares have gone down -51.86% during the last six months, with a year-to-date growth rate less than the industry average at 1.63% against 15.40. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -481.43% this quarter and then drop -30.50% in the quarter after that. In the rating firms’ projections, revenue will decrease -5.17% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 100.02M as predicted by 14 analyst(s). Meanwhile, a consensus of 11 analyst(s) estimates revenue growth to 94.64M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 116.18M and 101.9M respectively. In this case, analysts expect current quarter sales to shrink by -13.90% and then drop by -7.12% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -9.37%. While earnings are projected to return 5.26% in 2024.
NVRO Dividends
Nevro Corp is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Nevro Corp (NYSE:NVRO)’s Major holders
Nevro Corp insiders own 3.71% of total outstanding shares while institutional holders control 98.09%, with the float percentage being 101.87%. ARROWMARK COLORADO HOLDINGS LLC is the largest shareholder of the company, while 194.0 institutions own stock in it. As of 2024-06-30, the company held over 4.29 million shares (or 11.7615% of all shares), a total value of $36.11 million in shares.
The next largest institutional holding, with 3.67 million shares, is of ARMISTICE CAPITAL, LLC’s that is approximately 10.0693% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $30.92 million.
Also, the Mutual Funds coming in first place with the largest holdings of Nevro Corp (NVRO) shares are Vanguard Explorer Fund, Inc. and Vanguard Total Stock Market Index Fund . Data provided on Jul 31, 2024 indicates that Vanguard Explorer Fund, Inc. owns about 2.12 shares. This amounts to just over 5.65 percent of the company’s overall shares, with a $9.58 million market value. The same data shows that the other fund manager holds slightly less at 1.15, or about 3.08% of the stock, which is worth about $5.21 million.
